Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Market Cap
100B
Short interest (May 15)
0.3%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.41%
↓ 78.6%
Available Shares
3M
↑ 0.3%
Price Chart
Company Overview
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.